Colorectal tumour cells can be targeted using a combination treatment strategy involving in situ vaccination and Checkpoint Blockade Therapy. This dual approach enhances anti-tumour immune responses and leads to tumor cell shrinkage or death. (IMAGE)

ELSP

Colorectal tumour cells can be targeted using a combination treatment strategy involving in situ vaccination and Checkpoint Blockade Therapy. This dual approach enhances anti-tumour immune responses and leads to tumor cell shrinkage or death.

Caption

Colorectal tumour cells can be targeted using a combination treatment strategy involving in situ vaccination and Checkpoint Blockade Therapy. This dual approach enhances anti-tumour immune responses and leads to tumor cell shrinkage or death.

Credit

Tolulope A. Owolabi, Samson A. Adeyemi,*, Lindokuhle M. Ngema, Clement Penny and Yahya E. Choonara*/ Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa

Usage Restrictions

Credit must be given to the creator.

License

CC BY

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.